Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0SSFSR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DM001
|
|||||
| Synonyms |
DM 001; DM-001; DM001
Click to Show/Hide
|
|||||
| Organization |
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.; Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 3 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TROP2); Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
BCPT02
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
| Combination Type |
BLD1102
|
|||||
